Trial NCT05728736

View at ClinicalTrials.gov 
Org. Study IDs: HRPO 202210049

Last trial update was posted on 2023-11-08

MeSH Interventions

Lemborexant

MeSH Conditions

Alzheimer Disease

Other Conditions


Stopping Reasons

Study was terminated due to enrollment difficulties and the inability to obtain necessary study supplies. Five participants signed consent; however, no one was randomized. The study was officially terminated with the funding source on 10/04/2023.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID